MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Is essential tremor-plus phenotype a prodromal phase of Parkinson’s disease ?

    A. Rekik, A. Mili, H. Slimene, K. Jemai, E. Jarrar, A. Hassine, S. Naija, S. Ben Amor (Sousse, Tunisia)

    Objective: To study the probability of conversion of essential tremor (ET) and ET-plus patients to Parkinson's disease (PD). Background: ET-plus syndrome represents a wide spectrum…
  • 2024 International Congress

    Distinct pattern of synaptic loss in Parkinson’s disease depression and initial findings from the Yale Ketamine PD (KET-PD) trial

    M. Ansari, Y. Yang, S. Elliott, M. Naganawa, P. Honhar, M. Dias, S. Henry, J. Ropchan, R. Comley, N. Nabulsi, Y. Huang, R. Carson, S. Finnema, S. Nikayin, S. Tinaz, D. Matuskey, G. Sanacora, S. Holmes (New Haven, USA)

    Objective: To investigate synaptic loss in Parkinson's Disease depression (PDd) using PET and [11C]UCB-J (a marker for synaptic density) and present the initial blinded findings…
  • 2024 International Congress

    Oculomotor Biomarkers for Cerebellar Ataxia and Severity in Smooth Pursuit

    P. Ponger, G. Gurevich, R. Alcalay, Y. Bonneh, S. Shani (Tel Aviv, Israel)

    Objective: Our research utilizes the technique of brief linear smooth pursuit of a moving target, to derive various parameters. These parameters are then analyzed to…
  • 2024 International Congress

    Progressive cerebellar ataxia in primary Sjögren’s syndrome: a case report

    T. Nguyen, V. Le, K. Vo, T. Tran (Ho Chi Minh, Viet Nam)

    Objective: To present a rare case of gradually progressing cerebellar ataxia due to systemic autoimmune disease. Background: Primary Sjögren’s syndrome (pSS) is an autoimmune disease,…
  • 2024 International Congress

    Effects of Transpinal Magnetic Stimulation (TsMS) in Patients Diagnosed with Spinocerebellar Ataxia 3 (SCA 3)

    K. Silveira Massruha, R. Bernhart Carra, J. Simões, G. Nunes Simões, J. Reis Menezes, V. Zanesi Maciel, M. Belo Silva, P. Medeiros Lacerda, T. Gonçalves Guimarães, E. Reis Barbosa, R. Gisbert Cury (São Paulo, Brazil)

    Objective: Ataxia is a neurological condition characterized by impaired coordination, balance, and motor control. While physiotherapy remains a cornerstone in SCA 3 management, emerging therapies such…
  • 2024 International Congress

    Non Classified Spinocerebellar Ataxia-like Syndrome due to GYG-1 gene mutation with TPM3, GEMIN5 and DES mutations in a Peruvian family

    W. Trillo Alvarez, A. Escalante Mercado, D. Hito Cano, L. Delgado Villanueva, K. Choque Pereyra, E. Carrillo Monteagudo, P. Gonzales Romero (Arequipa, Peru)

    Objective: To report a GYG1 mutation in a Peruvian family presenting as a non classified Spinocerebellar Ataxia (SCA) with added GEMIN5, DES and TPM3 mutations.…
  • 2024 International Congress

    Movement disorders secondary to neurocysticercosis: a case report from Bolivia

    M. Jauregui, S. Silva, P. Chana-Cuevas, P. Salles (La Paz, Bolivia)

    Objective: The objective is the presentation of a movement disorder related to Taenia solium infection that produces neurocysticercosis. Background: The incidence of neurocysticercosis in Bolivia…
  • 2024 International Congress

    Diagnostic challenges with novel SCA variants: A case of STUB1 mutation

    D. Vijaywargiya, A. Frank, T. Chabrashvili (Liverpool, USA)

    Objective: We present a case of SCA48 found on multi-gene sequencing panel [MGSP] after negative dementia workup. Background: Spinocerebellar ataxia [SCA] is a genotypically &…
  • 2024 International Congress

    Assessment of Motor and Non-Motor Alterations Impacting Functionality in Parkinson’s Disease Patients

    R. Dias, M. Piemonte, G. Gomes, L. Bitaraes (Sao Paulo, Brazil)

    Objective: To investigate the impact of motor and non-motor changes on the functionality of individuals with Parkinson's disease Background: Parkinson's disease (PD) is the second…
  • 2024 International Congress

    Identification of Allosteric GCase Correctors Using Revenir™ for the Treatment of GBA1-Parkinson’s Disease

    J. Dupaul-Chicoine, S. Lavallée, N. Azevedo Portilho, L. Gong, M. Fournel, I. Ghosh, MR. Goldsmith, M. Ebert, O. Rousseau, L. Fader, JF. Marquis, S. Hedge (Saint-Laurent, Canada)

    Objective: To identify novel non-inhibitory allosteric correctors of GCase using Congruence Therapeutic’s in silico proprietary drug discovery engine, Revenir™ Background: GBA1 encoding for glucocerebrosidase (GCase)…
  • « Previous Page
  • 1
  • …
  • 333
  • 334
  • 335
  • 336
  • 337
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley